SM Journal of Sarcoma Research is an open access peer reviewed journal publishing articles committed to provide significant information on Sarcoma Immunotherapy, Improved drug delivery, new drugs, Targeted therapy, Targeted oncogene treatments, Tumor genetics, Palliative care/supportive care, etc. Our experienced team of experts provides editorial excellence, rapid publication, and high visi...Readmore |
Extraskeletal Myxoid Chondrosarcomas (EMC) are rare low-grade malignant mesenchymal neoplasms of uncertain differentiation characterized by abundant myxoid matrix. EMCs account for almost 3% of ... Download PDF
Garrett Jackson*, Yassin Nayel, Joseph Varney, Yeonjoo Cho, Ngowari Pokima, Hong Yu Wang, and Mohamed Aziz
Immune checkpoint inhibitors revive pre-existing immune responses that are suppressed in cancer. To restore innate tumour surveillance that is lost in cancer patients, a tumoricidal agent may ha... Download PDF
Sant P Chawla, K Kumar Sankhala, Joshua R Ravicz, Grace E Kang, Seiya Liu, Nupur Assudani, Shiva Sreenath Andrali, Nathan Stumpf, Bryan C Leong, Seth Kim, Suzan Arasheben,William Tseng, Don A Brigham and Erlinda M Gordon*
Soft tissue sarcomas (Sts) are rare tumors that make up about 1% of malignant neoplasms. In addition to their histological diversity, Stscan occur anywhere on the body but present predominance i... Download PDF
Giselle Almeida* (ICAVC), Lucas Jacometo Coelho de Castilho (ICAVC), Gisele Aparecida da Costa Gonçalves Pires1 (ICAVC), Priscila Souza Schinzari (UNISA) and Isabela Moraes Bernal (UNISA)
Vincristine, ifosfamide, doxorubicin and etoposide (VIDE) is an intensive multiagent induction chemotherapy regimen used in the treatment of Ewing and other sarcoma, most often in children and y... Download PDF
Brandon Lau, Peter Grimison and Vivek BhadriZ*
Background: Myxoid Leiomyosarcoma (LMS) is a rare and aggressive subtype of soft tissue sarcoma. Currently the true incidence and prognosis of myxoid leiomyosarcoma is unknown. This study examin... Download PDF
Jonathan Gootee, Elida Voth, Christina Curtin, Peter Silberstein and Leah Grant*
Introduction: In sarcoma, no attention has been given to targets beyond the PD-1/PD-L1 axis. We profiled the immune microenvironment of sarcoma with a focus on Undifferentiated Pleomorphic Sarco... Download PDF
Papanicolau-Sengos A*, De Pietro P, Pabla S, Lenzo F, Conroy J, Burgher B, Giamo V, Andreas J, Gardner M1, Glenn S and Morrison C
Synovial sarcoma is a rare soft tissue cancer occurring more frequently in adolescent and young adults than older people. The primary sites being the joints of the arms and the legs.
... Download PDFRoomi MW, Bhanap B, Ahmed T, Niedzwiecki A* and Rath M
Soft tissue sarcomas (STS) are a group of different diseases that differ in presentation, response to therapies and prognosis. Some new interesting approaches are becoming available in the treat... Download PDF
Alessandro Comandone*, Antonella Boglione, Teresa Mele, Paola Bergnolo and Orietta Dal Canton
The discovery of the driver mutation BRAF in melanoma has led to the emergence of new therapeutic treatments resulting in prolonged survival. By combining BRAF inhibitors with MEK inhibitors, me... Download PDF
Mary Jo Pilat, Naresh Bumma*, Jessica B Back, Trailokya Pandit and Amy M Weise
Background: Patients with a metastatic or locally advanced Soft Tissue Sarcoma (STS) are normally treated with chemotherapy. However, pretreated or vulnerable patients with comorbidities may hav... Download PDF
Marie Ahlstrom*, Maja Sloth and Mikael Eriksson
Director, Interventional Implant Program
MedStar Heart & Vascular Institute,
Washington, DC, USA
This work is licensed under a Creative Commons Attribution 4.0 International License.
